Butterfly Network Q1 Earnings Call Highlights

Butterfly Network (NYSE:BFLY) reported first-quarter 2026 results that management said reflected continued momentum across its core point-of-care ultrasound (POCUS) business and its growing Butterfly ...
Morningstar

Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women’s Health

The new AI-powered tool determines how far along a pregnancy is in minutes—providing critical information to guide timely care and help reduce maternal and fetal mortality worldwide. Butterfly Network ...

Butterfly projects Q2 revenue of $27M-$31M while reaffirming 2026 revenue of $117M-$121M

Q1 2026 earnings call: 25% revenue growth, 69% margin, FDA AI milestone, Embedded surge, and Q2/2026 guidance—read now.
Times Argus

Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women’s Health

Butterfly Network, Inc. (“Butterfly,” “the Company”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received ...